Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.
Mar 25, 2025
0
0
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC) and hepatic decompensation among patients with chronic liver disease (CLD). Statins, particularly ...
Acquired DNA mutations found in the SERPINA1 gene can protect liver cells from damage in patients with alpha-1 antitrypsin deficiency, new research shows. Alpha-1 antitrypsin deficiency (A1AD) is a genetic condition caused ...
Mar 10, 2025
0
6
A study from National Taiwan University Hospital has unveiled how metabolic dysfunction significantly influences the mortality risks of patients with chronic hepatitis B (CHB). The research, recently published in the Journal ...
Mar 7, 2025
0
0
Loneliness and social isolation have been linked to an elevated risk of non-alcoholic fatty liver disease (NAFLD), according to a study conducted by researchers from Central South University and the Army Medical University ...
Feb 12, 2025
0
1
Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist for at least 25 years after celiac diagnosis. The findings, published in The Lancet Regional Health—Europe, ...
Jan 10, 2025
0
1
Researchers have uncovered a significant mechanism involved in liver fibrosis. Their findings have been published in the journal Gut. The study highlights the extracellular matrix protein 1 (ECM1) as a central component of ...
Dec 9, 2024
0
0
The prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, boosted by increased obesity and sedentary lifestyles. MASLD (formerly known as non-alcoholic fatty ...
Dec 4, 2024
0
40
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.
Nov 26, 2024
0
0
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key biological reason why obesity increases the risk of type 2 diabetes, and it boils down to size—specifically ...
Nov 22, 2024
0
17
